Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-06 02:13:29 - browse：1198

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： AstraZeneca stays mum on Medicare drug pricing negotiations

WSS

Judge agrees to delay next hearing in Trump classified documents case

Wisconsin governor employs partial veto to fund schools for 4 centuries

Presidential fundraising highlights so far: Trump brings in more than DeSantis

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Home health providers sue Medicare over payment cuts

knowledge

Wikipedia

focus

Medical leaders decry Supreme Court decision on affirmative action

White House announces new plan to address the growing threat of xylazine in overdose crisis

Wildfire smoke exposes gaps in outdoor worker protections

Judge agrees to delay next hearing in Trump classified documents case

Cancer drug shortages should be causing more outrage

AstraZeneca stays mum on Medicare drug pricing negotiations

Dobbs anniversary: the lost opportunity of abortion as health care

Devoted Health’s losses in Medicare Advantage persist

Hepatitis C has a cure — but many Americans still lack access to it

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

hotspot

AstraZeneca stays mum on Medicare drug pricing negotiations

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Why Novartis is going to walk from its acquisition of MorphoSys

A protest over insulin prices is seen as a fight for life

The Biogen Aduhelm mess could happen again

A protest over insulin prices is seen as a fight for life

knowledge

leisure time

explore

focus